Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dexmedetomidine can prolong the duration of local anesthetics, but the effect of perineural dexmedetomidine on the potency of ropivacaine for brachial plexus blocks in pediatric patients has not been investigated. This study was designed to determine the effect of perineural dexmedetomidine on ropivacaine for brachial plexus blocks in pediatric patients
150 children scheduled for arm and forearm surgery underwent supraclavicle brachial plexus blocks with ropivacaine guided by ultrasound visualisation were randomly assigned to one of the five groups: Group A (perineural ropivacaine), Group B (ropivacaine plus 0.5 mcg/kg dexmedetomidine), Group C (ropivacaine plus 1 mcg/kg dexmedetomidine), Group D (ropivacaine plus 1.5mcg/kg dexmedetomidine) and Group E (ropivacaine plus 2 mcg/kg dexmedetomidine). The primary endpoint was the minimum local anesthetic concentration (MLAC), which was determined using the Dixon up-and-down method. The secondary endpoints were the duration of analgesia and sedation
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| saline (Group A) | Active Comparator | perineural ropivacaine |
|
| 0.5 mcg/kg dexmedetomidine (Group B) | Active Comparator | (perineural ropivacaine plus 0.5 mcg/kg dexmedetomidine), |
|
| 1 mcg/kg dexmedetomidine (Group C) | Active Comparator | (perineural ropivacaine plus 1 mcg/kg dexmedetomidine) |
|
| 1.5 mcg/kg dexmedetomidine (Group D) | Active Comparator | (perineural ropivacaine plus 1.5mcg/kg dexmedetomidine) |
|
| 2 mcg/kg dexmedetomidine (Group E) | Active Comparator | (perineural ropivacaine plus 2 mcg/kg dexmedetomidine) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| perineural dexmedetomidine | Drug | Children scheduled for arm and forearm surgery underwent supraclavicle brachial plexus blocks with ropivacaine and dexmedetomidine guided by ultrasound visualisation were randomly assigned five groups: Group A (perineural ropivacaine), Group B (ropivacaine plus 0.5 mcg/kg dexmedetomidine), Group C (ropivacaine plus 1 mcg/kg dexmedetomidine), Group D (ropivacaine plus 1.5mcg/kg dexmedetomidine) and Group E (ropivacaine plus 2 mcg/kg dexmedetomidine). In each group, children received a certain concentration of ropivacaine which adjusted by the "Dixon up-and-down method for supraclavicle brachial plexus. The first child received 0.2% ropivacaine , and the concentration of ropivacaine varied by 0.1% according to the up-and-down method. The primary endpoint was the minimum local anesthetic concentration (MLAC). |
| Measure | Description | Time Frame |
|---|---|---|
| the minimum local anesthetic concentration (MLAC) | For each patient, the target concentration of perineural ropivacaine was determined using the modified Dixon's up-and-down method starting with 0.20% in each group, varied with 0.1% as a step size. Increasing or decreasing the target concentration of perineural ropivacaine was determined by the response of the previous child in the same group. The response of each child was observed for 60 s after the skin incision and evaluated as 'successful' or 'unsuccessful.' 'Unsuccessful' was recorded when skin incision caused motor responses or change in hemodynamic parameters (heart rate and mean blood pressure) more than 20% of the preincision values. If the response was determined to be unsuccessful, the concentration of perineural ropivacaine given to the next patient would be increased by 0.1%. If it was successful, the concentration of caudal levobupivacaine given to the next patient would be decreased by 0.1% | up to 30 minutes after brachial plexus blocks |
| Postoperative pain | The Face, Legs, Activity, Cry, Consolability scale or FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain, 1-3 representing mild uncomfortable, 4-6 representing moderate pain, 7-10 representing high-level pain or/and uncomfort. The FLACC scale was evaluated at 6 and 12 hours postoperatively, and scale of ≥4 points was regarded as an inadequate analgesia and was managed with 10 mg/kg of ibuprofen by mouth every 6 h as required | up to 12 hours after brachial plexus blocks |
| The sedation status | Sedation status was evaluated by a attending anesthesiologists with a 6-point sedation scale, which was modified from the Modified Observer Assessment of Alertness and Sedation Scale (MOAA/S). The MOAA/S scale was evaluated at 6 and 12 hours postoperatively 0 Does not respond to a noxious stimulus
|
| Measure | Description | Time Frame |
|---|---|---|
| pulse oximetry | Significant Oxyhemoglobin desaturation was defined as < 90% | up to 12 hours after brachial plexus blocks |
| heart rate | Bradycardia was defined as a reduction in heart rate more than 20% from the baseline values |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| up to 12 hours after brachial plexus blocks |
| up to 12 hours after brachial plexus blocks |
| noninvasive arterial blood pressure | Hypotension was defined as a reduction in systolic blood pressure more than 20% from the baseline values | up to 12 hours after brachial plexus blocks |